CIAM
TTRX

Caitong International Asset Management’s Turn Therapeutics TTRX Stock Holding History

Caitong International Asset Management’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226 Buy
+31
New +$144 ﹤0.01% 1973

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BA
Bridgewater Advisors New York $1.83B AUM 22.9% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return

Caitong International Asset Management's TTRX Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Turn Therapeutics (TTRX) in Q2 2026: 31 shares worth $226. The stake represents ﹤0.01% of the portfolio and ranks #1973 among its holdings.

29 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • Caitong International Asset Management held 31 shares of Turn Therapeutics worth $226 as of Q2 2026.
  • Turn Therapeutics was a new Caitong International Asset Management position in Q2 2026.
  • Turn Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1973 holding.
  • 29 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.